USA: +1 617 939 9497 | UK: +44 2039 962936 | EU: +34 607 939 266 info@sofpromed.com
Select Page

Benefits of Clinical Research Site Networks in Illinois

Patricio Ledesma

Head Of Clinical Operations at Sofpromed

29 February, 2024

Benefits of Clinical Research Site Networks in Illinois

If you are a Sponsor interested in running a clinical trial through a clinical research site network in Illinois, please contact us at info@sofpromed.com

Clinical site networks play a central role in advancing medical research and improving patient care.

In this article you will learn about:

In Illinois, several clinical site networks have emerged, offering a wide range of services, collaborations, and resources to researchers, healthcare professionals, and patients.

These networks serve as vital hubs for conducting clinical trials, enhancing research capabilities, and fostering innovation in healthcare.

The Importance of Clinical Research Site Networks

Clinical research site networks serve as a critical infrastructure for conducting clinical trials and research studies.

They bring together multiple healthcare institutions, academic centers, and private practices, creating a collaborative environment for researchers to exchange knowledge, resources, and expertise.

By leveraging these networks, researchers can enhance their study capabilities, access diverse patient populations, and accelerate the development of new treatments and therapies.

University of Illinois Chicago Center for Clinical and Translational Science

The University of Illinois Chicago (UIC) Center for Clinical and Translational Science (CCTS) is a leading clinical site network in Illinois.

It offers a wide range of resources, consultations, and funding opportunities to support multisite clinical trials.

The CCTS provides access to federally funded resources, including the Trial Innovation Network (TIN) and the ACT Network.

These resources enable researchers to expand the reach of their clinical studies and facilitate collaborations with other institutions.

Trial Innovation Network (TIN)

The Trial Innovation Network (TIN) is a collaborative national network that focuses on operational innovation, excellence, and collaboration in clinical trials.

As part of the CCTS, UIC investigators can benefit from the TIN’s broad range of services, consultations, and support.

The TIN offers assistance with trial planning, recruitment feasibility assessment, cohort discovery, site selection, and standardized agreements.

By connecting with UIC’s TIN Liaison, researchers can tap into the expertise and diverse patient populations available through the Clinical and Translational Science Awards (CTSA) consortium.

ACT Network

The ACT Network, developed collaboratively by members of the CTSA consortium, is a federated data network of leading academic medical centers.

It serves as a HIPAA-compliant and IRB-approved cohort discovery tool, allowing investigators to conduct EHR-based research on any disease or condition across the network of over 142 million patients.

The ACT Network enables researchers to explore patient cohorts, identify additional trial sites, and improve the efficiency of their clinical protocols.

The ENACT Network

Another notable clinical site network in Illinois is the ENACT Network, accessible through the CCTS.

The ENACT Network is a federated data network of academic medical centers within the CTSA consortium.

It offers various services, including cohort discovery and assistance with SMART IRB processes.

Through the ENACT Network, researchers can expand the reach of their clinical studies, access a vast patient population, and collaborate with other institutions.

Benefits of Participating in Clinical Site Networks

Participating in clinical site networks in Illinois offers numerous benefits for researchers, healthcare professionals, and patients alike.

Some of the key benefits include:

Access to Diverse Patient Populations

Clinical research site networks provide access to diverse patient populations, allowing researchers to study the efficacy and safety of treatments across different demographics and backgrounds.

Collaboration and Knowledge Exchange

Networks foster collaboration and facilitate the exchange of knowledge, resources, and expertise among researchers, promoting innovation and enhancing research capabilities.

Streamlined Trial Processes

Clinical research site networks offer support and services to streamline trial processes, including trial planning, recruitment feasibility assessment, site selection, and standardized agreements.

This helps researchers save time and resources, ensuring efficient study conduct.

Access to Specialized Services

Networks often have access to specialized services, such as central laboratories, radiology departments, and infusion centers.

This enables researchers to conduct comprehensive studies with seamless access to necessary ancillary services.

Funding Opportunities

Clinical research site networks often provide funding opportunities, such as pilot grants, to support research projects.

These funding opportunities can be instrumental in initiating and sustaining research efforts.

Conclusion

Clinical research site networks in Illinois play a vital role in advancing medical research, improving patient care, and fostering collaborations among healthcare institutions.

The University of Illinois Chicago Center for Clinical and Translational Science, with its Trial Innovation Network and ACT Network, offers extensive resources and support to researchers.

The ENACT Network provides access to a federated data network, enabling researchers to expand their clinical studies’ reach.

By participating in these networks, researchers, healthcare professionals, and patients can benefit from enhanced research capabilities, improved patient outcomes, and accelerated medical advancements.

If you are a Sponsor interested in running a clinical trial through a clinical research site network in Illinois, please contact us at info@sofpromed.com

Patricio Ledesma

Patricio Ledesma (B.Eng Concordia University, Montreal, Canada and Master’s Degree in Clinical Trials, University of Seville, Spain) is the Head of Clinical Operations and Founder at Sofpromed CRO. Patricio is a professional consultant providing comprehensive, one-stop expert advice and guidance to biotechnology and pharmaceutical companies worldwide in the field of clinical trials and drug development. He is personally and enthusiastically devoted to helping biotech Chief Executive, Operations, Scientific, Medical, and Regulatory Officers in the planning and execution of phase I-IV clinical trials across North America, Europe, Asia-Pacific, Latin America, and Middle East regions. You can contact Patricio at: +34 607 939 266  pledesma@sofpromed.com 

You may also be interested…

Patricio Ledesma

Patricio Ledesma (B.Eng Concordia University, Montreal, Canada and Master’s Degree in Clinical Trials, University of Seville, Spain) is the Head of Clinical Operations and Founder at Sofpromed CRO. Patricio is a professional consultant providing comprehensive, one-stop expert advice and guidance to biotechnology and pharmaceutical companies worldwide in the field of clinical trials and drug development. He is personally and enthusiastically devoted to helping biotech Chief Executive, Operations, Scientific, Medical, and Regulatory Officers in the planning and execution of phase I-IV clinical trials across North America, Europe, Asia-Pacific, Latin America, and Middle East regions. You can contact Patricio at: +34 607 939 266 pledesma@sofpromed.com